Common Stock, Shares, Outstanding of Fortress Biotech, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Fortress Biotech, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Fortress Biotech, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 31,005,170, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Fortress Biotech, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 31,005,170 +3,420,570 +12% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 29,752,795 +7,165,757 +32% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 29,554,966 +10,179,623 +53% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 27,908,839 +12,815,786 +85% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 27,584,600 +18,647,013 +209% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 22,587,038 -109,070,331 -83% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 19,375,343 -111,041,818 -85% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 15,093,053 +7,726,770 +105% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 8,937,587 -99,321,766 -92% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 131,657,369 +23,939,722 +22% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 130,417,161 +24,095,286 +23% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 7,366,283 -94,069,222 -93% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 108,259,353 +9,545,131 +9.7% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 107,717,647 +10,222,403 +10% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 106,321,875 +9,058,821 +9.3% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 101,435,505 +6,558,013 +6.9% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 98,714,222 +4,965,848 +5.3% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 97,495,244 +11,381,913 +13% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 97,263,054 +18,690,885 +24% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 94,877,492 +20,850,067 +28% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 93,748,374 +23,412,840 +33% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 86,113,331 +28,267,884 +49% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 78,572,169 +15,445,648 +24% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 74,027,425 +16,181,978 +28% 31 Dec 2019 10-K/A 09 Apr 2021 2020 FY
Q3 2019 70,335,534 +14,152,054 +25% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 57,845,447 +3,858,373 +7.1% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 63,126,521 +10,439,984 +20% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 57,845,447 +6,854,162 +13% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 56,183,480 +5,598,543 +11% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 53,987,074 +3,523,829 +7% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 52,686,537 +2,366,618 +4.7% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 50,991,285 +2,059,262 +4.2% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 50,584,937 +1,709,850 +3.5% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 50,463,245 +1,794,615 +3.7% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 50,319,919 +1,802,470 +3.7% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 48,932,023 +1,784,991 +3.8% 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q3 2016 48,875,087 +1,741,372 +3.7% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 48,668,630 +1,834,915 +3.9% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 48,517,449 +1,698,415 +3.6% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 47,147,032 +652,998 +1.4% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q3 2015 47,133,715 +2,821,522 +6.4% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 46,833,715 +2,521,522 +5.7% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 46,819,034 +2,565,647 +5.8% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 46,494,034 +6,841,084 +17% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 44,312,193 +9,056,513 +26% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 44,312,193 +14,706,669 +50% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 44,253,387 +18,085,627 +69% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 39,652,950 +15,252,196 +63% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 35,255,680 -24,340,493,320 30 Sep 2013 10-Q 01 Nov 2013 2013 Q3
Q2 2013 29,605,524 +5,229,775 +21% 30 Jun 2013 10-Q 05 Aug 2013 2013 Q2
Q1 2013 26,167,760 +7,563,515 +41% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 24,400,754 +5,796,509 +31% 31 Dec 2012 10-K 14 Mar 2014 2013 FY
Q3 2012 24,375,749,000* +24,368,720,940 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 24,375,749 30 Jun 2012 10-Q 08 Aug 2012 2012 Q2
Q1 2012 18,604,245 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 18,604,245 +13,813,143 +288% 31 Dec 2011 10-K 18 Mar 2013 2012 FY
Q3 2011 7,028,060 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q4 2010 4,791,102 31 Dec 2010 10-K 29 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.